|
Cellgenea conforms to the regulation of the Hellenic Data
Protection Authority, which deals with the protection of human rights in Greece,
according to the regulation Ν.
2472/1997 και
3471/2006.
Main goal of this authority is the protection of any citizen from the illegal procession of personal data, as well
as the contribution to
anyone facing problems with any illegal violation of personal data.
The Hellenic Data Protection Authority focuses, among others, to the
observation and the treatment of issues coming form the evolution of the
advanced technologies.
References
Η CellgeneaTM εφαρμόζει πλήρως όλες τις διατάξεις της Αρχής Προστασίας
Δεδομένων Προσωπικού Χαρακτήρα. Αποστολή της Αρχής αποτελεί η προστασία των
δικαιωμάτων της προσωπικότητας και της ιδιωτικής ζωής του ατόμου στην Ελλάδα,
σύμφωνα με τις διατάξεις των Ν. 2472/1997 και 3471/2006.
Πρωταρχικός σκοπός της Αρχής είναι η
προστασία του πολίτη από την παράνομη επεξεργασία των προσωπικών του δεδομένων,
αλλά και η συνδρομή προς αυτόν σε κάθε περίπτωση που διαπιστώνεται παραβίαση
των σχετικών δικαιωμάτων του σε κάθε επιχειρησιακό τομέα (χρηματοπιστωτικά,
υγεία, ασφάλιση, εκπαίδευση, δημόσια διοίκηση, μεταφορές, ΜΜΕ, κ.ο.κ).
Επίσης, σκοπός της Αρχής είναι η
υποστήριξη και καθοδήγηση των υπεύθυνων επεξεργασίας στην εκπλήρωση των
υποχρεώσεων τους απέναντι στο νόμο, λαμβάνοντας υπόψη τις νέες ανάγκες
υπηρεσιών της ελληνικής κοινωνίας, καθώς και την διείσδυση των σύγχρονων
ψηφιακών επικοινωνιών και δικτύων. Ως εκ τούτου, η Αρχή στρέφει ιδιαίτερα την
προσοχή της μεταξύ άλλων στην παρατήρηση και αντιμετώπιση ζητημάτων που
προκύπτουν με την εξέλιξη των νέων τεχνολογιών και εφαρμογών.
Aναφορές
I. USA
FDA
http://www.fda.gov/default.htm
FDA/CBER
http://www.fda.gov/cber/index.html
FDA Cellular & Gene Therapy
Publications
http://www.fda.gov/cber/genetherapy/gtpubs.htm
1)Tissue Rules
・Guidance for
Industry: Eligibility Determination for Donors of Human Cells, Tissues, and
Cellular and Tissue-Based Products - 8/8/2007
http://www.fda.gov/cber/gdlns/tissdonor.htm
2)Cellular
& Gene Therapy Rules
・Guidance for FDA
Reviewers and Sponsors: Content and Review of Chemistry, Manufacturing, and
Control (CMC) Information for Human Somatic Cell Therapy Investigational New
Drug Applications (INDs) - 4/9/2008
http://www.fda.gov/cber/gdlns/cmcsomcell.htm
・Guidance for FDA
Reviewers and Sponsors: Content and Review of Chemistry, Manufacturing, and
Control (CMC) Information for Human Gene Therapy Investigational New Drug
Applications (INDs) - 4/9/2008
http://www.fda.gov/cber/gdlns/gtindcmc.htm
3)How to
approach to cell-based therapy
・Points to Consider
in the Characterization of Cell Lines Used to Produce Biologicals ミ
7/12/1993
http://www.fda.gov/cber/gdlns/ptccell.pdf
・Application of
Current Statutory Authorities to Human Somatic Cell Therapy Products and Gene
Therapy Products; Notice - 10/14/1993
http://www.fda.gov/cber/genadmin/fr101493.pdf
・Proposed Approach
to Regulation of Cellular and Tissue-Based Products - 2/28/1997
http://www.fda.gov/cber/gdlns/celltissue.pdf
・Reinventing the
Regulation of Human Tissue
http://www.fda.gov/cber/tissue/rego.htm
http://www.fda.gov/cber/tissue/regotab.pdf
(Table)
II.
Europe
EMEA
http://www.emea.europa.eu/
EMEA / Committee for Medicinal Products for Human Use (CHMP)
http://www.emea.europa.eu/htms/general/contacts/CHMP/CHMP.html
EudraLex / The Rules Governing Medicinal Products in the European Union
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/index.htm
1) Tissue Rule
・ The
tissues and cells directive (2004/23/EC)
http://www.who.int/ethics/en/ETH_EU_Directive_2004_23_EC.pdf
2) GCP Rules
・ The
clinical trials directive (2001/20/EC、2005/28/EC)
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2005_28/dir_2005_28_en.pdf
3) Authorization Rules
・ the
medicinal products directive (2001/83/EC, 2003/63/EC)
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2001_83/dir_2001_83_en.pdf
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2003_63/dir_2003_63_en.pdf
・ the
medical devices directive (93/42/EEC)
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31993L0042:EN:HTML
・
Regulation on Advanced therapy medicinal products (Regulation (EC) No 726/2004)
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/reg_2007_1394/reg_2007_1394_en.pdf
4) GMP Rules
・GMP
directives (2003/94/EC)
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-1/dir_2003_94/dir_2003_94_en.pdf
・EU
Guidelines to Good Manufacturing Practice Medicinal Products for Human and
Veterinary Use
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/homev4.htm
5) Guideline on human cell-based medicinal products (EMEA/CHMP)
http://www.emea.europa.eu/pdfs/human/cpwp/41086906en.pdf
6) Pharmacovigilance Rules
・EudraLex
Volume 9A(Pharmacovigilance
for medicinal products for Human use)
http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-9/pdf/vol9_2007-07_upd07.pdf
III.
UK
MHRA
http://www.mhra.gov.uk/index.htm
HTA (Human Tissue Authority)
http://www.hta.gov.uk/
HFEA (Human Fertilisation &
Embryology Authority) http://www.hfea.gov.uk/
National Institute for Biological
Standards and Control http://www.nibsc.ac.uk/
UK Stem Cell Bank
http://www.ukstemcellbank.org.uk/
1) Tissue Rules
・the
Human Tissue Act (2004)
http://www.opsi.gov.uk/acts/acts2004/ukpga_20040030_en_1
2) ES cells Rules
・The
Human Fertilisation and Embryology (HFE) Act (1990)
http://www.opsi.gov.uk/acts/acts1990/Ukpga_19900037_en_1.htm
・Code of
practice for the use of human stem cell lines (UK stem cell Bank, 2005)
http://www.ukstemcellbank.org.uk/documents/Code%20of%20Practice%20for%20
the%20Use%20of%20Human%20Stem%20Cell%20Lines.pdf
3) GCP Rules
・UK
Statutory Instrument 2004 No.1031(The Medicines for human use clinical trials
regulations)
http://www.opsi.gov.uk/si/si2004/20041031.htm
4) GMP Rules
・The
Code of Practice for the Production of Human-derived Therapeutic Products
(MHRA, 2002)
http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&dDocName=CON007432
&RevisionSelectionMethod=LatestReleased
|